Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTUGLIFLOZIN PIDOLATE vs ESMOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERTUGLIFLOZIN PIDOLATE vs ESMOLOL: Safety Overview

Metric ERTUGLIFLOZIN PIDOLATE ESMOLOL
Total FAERS Reports 681 565
Deaths Reported 4 51
Death Rate 0.6% 9.0%
Hospitalizations 128 255
Average Patient Age 57.0 yrs 36.9 yrs
% Female Patients 56.1% 44.7%
FDA Approval Date N/A Apr 7, 2016
Manufacturer Merck Sharp & Dohme LLC HF Acquisition Co LLC, DBA HealthFirst
Route ORAL INTRAVENOUS
Marketing Status N/A Discontinued